SCHEMBL1918512

SCHEMBL1918512

CC(=O)N1CCCC1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23785996 1.00 — —
SCHEMBL3259043 0.94 CHRM2 (0.42) —
SCHEMBL5739697 0.93 CHRM2 (0.49) —
SCHEMBL15971525 0.86 — —
SCHEMBL14878574 0.79 POLB (0.41) —
SCHEMBL30489287 0.79 — —
SCHEMBL21773024 0.79 — —
SCHEMBL3488662 0.79 — —
SCHEMBL19408961 0.79 — —
SCHEMBL18629522 0.77 POLB (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152342-A1 STABILIZED PHARMACEUTICAL COMPOSITION KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-06-23 — — US claimed
EP-2327406-A1 STABILIZED PHARMACEUTICAL COMPOSITION Kyorin Pharmaceutical Co., Ltd. (JP) 2011-06-01 — — EP claimed
WO-2024049543-A1 COMPOSITIONS AND METHODS FOR TRANSGLUTAMINASE-MEDIATED ENDOCYTOSIS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2024-03-07 — — WO disclosed
EP-3309157-B1 ANTIVIRAL COMPOUNDS GILEAD PHARMASSET LLC (US) 2019-09-04 — — EP disclosed
EP-3309157-A1 ANTIVIRAL COMPOUNDS Gilead Pharmasset LLC (US) 2018-04-18 — — EP disclosed
EP-3002281-B1 ANTIVIRAL COMPOUNDS GILEAD PHARMASSET LLC (US) 2017-09-13 — — EP disclosed
WO-2010092015-A1 UREA TRIAZOLOLO [1, 5-A] PYRIDINE DERIVATIVES AS PI3K INHIBITORS CELLZOME LIMITED (GB) 2010-08-19 — — WO disclosed
Send feedback